Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Delta Sleep Inducing Peptide
2. Delta Sleep Peptide
3. Delta Sleep-inducing Peptide
4. Delta-sleep Peptide
5. Delta-sleep-inducing Peptide
6. Delta-sleep-inducing-peptide
7. Dsip
8. Peptide, Delta Sleep-inducing
9. Peptide, Delta-sleep
10. Peptide, Delta-sleep-inducing
11. Sleep-inducing Peptide, Delta
12. Trp Ala Gly Gly Asp Ala Ser Gly Glu
13. Trp-ala-gly-gly-asp-ala-ser-gly-glu
1. 62568-57-4
2. Dsip
3. Delta Sleep Inducing Peptide
4. Trp-ala-gly-gly-asp-ala-ser-gly-glu
5. Delta Sleep-inducing Peptide
6. Dsip Nonapeptide
7. Emideltide [inn]
8. L-tryptophyl-l-alanylglycylglycyl-l-aspartyl-l-alanyl-l-serylglycyl-l-glutamic Acid
9. Delta Sleep-inducing Peptide (rabbit)
10. Unii-yn28z5yz73
11. Delta-sleep Inducing Peptide
12. O-sleep Inducing Peptide
13. Deltasleep-inducing Peptide
14. L-glutamic Acid, L-tryptophyl-l-alanylglycylglycyl-l-alpha-aspartyl-l-alanyl-l-serylglycyl-
15. 69431-45-4
16. L-glutamic Acid, N-(n-(n-(n-(n-(n-(n-(n-l-tryptophyl-l-alanyl)glycyl)glycyl)-l-alpha-aspartyl)-l-alanyl)-l-seryl)-glycyl)-
17. Schembl5523017
18. Yn28z5yz73
19. Chembl2104403
20. Dtxsid20978151
21. Glxc-25919
22. Hy-p1501
23. Zinc169292552
24. L-tryptophyl-l-alanylglycylglycyl-l-alpha-aspartyl-l-alanyl-l-serylglycyl-l-glutamic Acid
25. Cs-0044577
26. H-trp-ala-gly-gly-asp-ala-ser-gly-glu-oh
27. Delta-sleep Inducing Peptide Trifluoroacetate Salt
28. Q27294600
29. L-tryptophyl-l-alanyl-glycyl-glycyl-l-alpha-aspartyl-l-alanyl-l-seryl-glycyl-l-glutamic Acid
30. (2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]propanoyl]amino]acetyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]pentanedioic Acid
31. (3s,9s,12s,15s)-15-(2-(2-((s)-2-((s)-2-amino-3-(1h-indol-3-yl)propanamido)propanamido)acetamido)acetamido)-9-(hydroxymethyl)-12-methyl-5,8,11,14-tetraoxo-4,7,10,13-tetraazahexadecane-1,3,16-tricarboxylic Acid
32. N-[23-amino-11-(carboxymethyl)-1,4,7,10,13,16,19,22-octahydroxy-5-(hydroxymethyl)-24-(1h-indol-3-yl)-8,20-dimethyl-3,6,9,12,15,18,21-heptaazatetracosa-3,6,9,12,15,18,21-heptaen-1-ylidene]glutamic Acid
Molecular Weight | 848.8 g/mol |
---|---|
Molecular Formula | C35H48N10O15 |
XLogP3 | -7.1 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 25 |
Exact Mass | 848.33006086 g/mol |
Monoisotopic Mass | 848.33006086 g/mol |
Topological Polar Surface Area | 407 Ų |
Heavy Atom Count | 60 |
Formal Charge | 0 |
Complexity | 1610 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Neurotransmitter Agents
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)
ABOUT THIS PAGE
54
PharmaCompass offers a list of Emideltide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Emideltide manufacturer or Emideltide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Emideltide manufacturer or Emideltide supplier.
PharmaCompass also assists you with knowing the Emideltide API Price utilized in the formulation of products. Emideltide API Price is not always fixed or binding as the Emideltide Price is obtained through a variety of data sources. The Emideltide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Emideltide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emideltide, including repackagers and relabelers. The FDA regulates Emideltide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emideltide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Emideltide supplier is an individual or a company that provides Emideltide active pharmaceutical ingredient (API) or Emideltide finished formulations upon request. The Emideltide suppliers may include Emideltide API manufacturers, exporters, distributors and traders.
click here to find a list of Emideltide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Emideltide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Emideltide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Emideltide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Emideltide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Emideltide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Emideltide suppliers with NDC on PharmaCompass.
Emideltide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Emideltide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Emideltide GMP manufacturer or Emideltide GMP API supplier for your needs.
A Emideltide CoA (Certificate of Analysis) is a formal document that attests to Emideltide's compliance with Emideltide specifications and serves as a tool for batch-level quality control.
Emideltide CoA mostly includes findings from lab analyses of a specific batch. For each Emideltide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Emideltide may be tested according to a variety of international standards, such as European Pharmacopoeia (Emideltide EP), Emideltide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emideltide USP).